Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Arbuckle Stuart A
Relationship:   Director
City:   Cambridge,
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   62,795    

Indirect Shares

  140      
Direct Value   $22,712,016    

Indirect Value

  $63,973      
Total Shares   62,935      
Total Value   $22,775,989      


Vertex Pharmaceuticals Inc
 $22,706,302 Dare Bioscience Inc
 $5,713 Vertex Pharmaceuticals Inc
 $22,706,302 Dare Bioscience Inc
 $5,713
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP, COO 2024-05-15 49,691 2024-05-15 140    Premium*  
            Dare Bioscience Inc DARE Director 2017-01-03 13,104 2016-10-03 0    Premium*  
            Immunogen Inc IMGN Director 2024-02-12 0 2023-06-30 0    Premium*  
* Premium Members only  

Records found :    192         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-02-11 4 AS $243.76 $2,777,325 D/D (11,286) 47,335 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-02-17 4 D $241.50 $602,784 D/D (2,496) 44,839 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-02-18 4 AS $242.08 $761,842 D/D (3,128) 41,711 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-02-24 4 D $239.23 $693,289 D/D (2,898) 38,813 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-02-25 4 AS $229.78 $849,418 D/D (3,634) 35,179 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-05-04 4 OE $86.52 $134,366 D/D 1,553 36,732 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-05-04 4 AS $259.36 $404,957 D/D (1,553) 35,179 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-05-15 4 AS $276.35 $32,089 D/D (113) 35,179 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-07-07 4 OE $155.57 $483,403 D/D 2,786 37,965 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-07-07 4 AS $300.00 $835,800 D/D (2,786) 35,179 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-08-03 4 OE $86.52 $134,366 D/D 1,553 36,732 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-08-03 4 AS $276.40 $432,337 D/D (1,553) 35,179 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-11-03 4 AS $210.56 $329,115 D/D (1,553) 35,179 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-11-03 4 OE $86.52 $134,366 D/D 1,553 36,732 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-11-16 4 AS $222.47 $1,565 D/D (7) 35,179 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-03 4 A $0.00 $0 D/D 34,778 69,957 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-03 4 OE $86.52 $134,452 D/D 1,554 71,511 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-03 4 AS $211.22 $332,146 D/D (1,554) 69,957 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-10 4 D $214.16 $664,110 D/D (3,101) 66,856 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-11 4 AS $210.39 $1,085,593 D/D (5,156) 61,700 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-17 4 D $211.75 $1,321,320 D/D (6,240) 55,460 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-18 4 AS $210.05 $1,657,481 D/D (7,825) 47,635 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-24 4 D $217.57 $630,518 D/D (2,898) 44,737 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-25 4 AS $211.39 $775,989 D/D (3,634) 41,103 0 %
VRTX Vertex Pharmaceuticals In... EVP, Chief Comm & Ops Officer   •       –      –    2021-05-17 4 AS $215.33 $23,589 D/D (109) 41,103 0 %

  192  Records found
  1   2   3   4   5   6  7   8      
  Page 6 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed